These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses. Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587 [TBL] [Abstract][Full Text] [Related]
4. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients. Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095 [TBL] [Abstract][Full Text] [Related]
5. Serum IGFBP2 Level Is a New Candidate Biomarker of Severe Malnutrition in Advanced Lung Cancer. Dong J; Zeng Y; Zhang P; Li C; Chen Y; Li Y; Wang K Nutr Cancer; 2020; 72(5):858-863. PubMed ID: 32286106 [No Abstract] [Full Text] [Related]
6. Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels. Ahmed AA; Abdou AM Curr Probl Cancer; 2019 Oct; 43(5):450-460. PubMed ID: 30670303 [TBL] [Abstract][Full Text] [Related]
7. The differential diagnostic value and clinical significance of serum HE4 in ovarian disease with elevated CA125. Li W; Wang D Arch Gynecol Obstet; 2020 May; 301(5):1219-1225. PubMed ID: 32266526 [TBL] [Abstract][Full Text] [Related]
8. Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study. Feng LY; Liao SB; Li L J Ovarian Res; 2020 Feb; 13(1):17. PubMed ID: 32050995 [TBL] [Abstract][Full Text] [Related]
9. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer. Singh A; Gupta S; Badarukhiya JA; Sachan M Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343 [TBL] [Abstract][Full Text] [Related]
10. A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours. Russell MR; Graham C; D'Amato A; Gentry-Maharaj A; Ryan A; Kalsi JK; Ainley C; Whetton AD; Menon U; Jacobs I; Graham RLJ Br J Cancer; 2017 Aug; 117(5):666-674. PubMed ID: 28664912 [TBL] [Abstract][Full Text] [Related]
11. Preoperative serum levels of insulin-like growth factor-binding protein 2 predict prognosis of gastric cancer patients. Hur H; Yu EJ; Ham IH; Jin HJ; Lee D Oncotarget; 2017 Feb; 8(7):10994-11003. PubMed ID: 28036255 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of serum D-dimer, CA125, and neutrophil-to-lymphocyte ratio in differentiating ovarian cancer and endometriosis. Chen L; Wang X; Shu J; Xu S; Wu Q; Yu Y Int J Gynaecol Obstet; 2019 Nov; 147(2):212-218. PubMed ID: 31469423 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis. Suri A; Perumal V; Ammalli P; Suryan V; Bansal SK Sci Rep; 2021 Aug; 11(1):17308. PubMed ID: 34453074 [TBL] [Abstract][Full Text] [Related]
14. Preoperative plasma IGFBP2 is associated with nodal metastasis in patients with penile squamous cell carcinoma. Hu X; Chen M; Liu W; Li Y; Fu J Urol Oncol; 2019 Jul; 37(7):452-461. PubMed ID: 31053522 [TBL] [Abstract][Full Text] [Related]
15. Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer. Kendrick ZW; Firpo MA; Repko RC; Scaife CL; Adler DG; Boucher KM; Mulvihill SJ HPB (Oxford); 2014 Jul; 16(7):670-6. PubMed ID: 24308545 [TBL] [Abstract][Full Text] [Related]
16. Tissue CA125 and HE4 Gene Expression Levels Offer Superior Accuracy in Discriminating Benign from Malignant Pelvic Masses. Fawzy A; Mohamed MR; Ali MA; Abd El-Magied MH; Helal AM Asian Pac J Cancer Prev; 2016; 17(1):323-33. PubMed ID: 26838232 [TBL] [Abstract][Full Text] [Related]
17. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma. Patel D; Ellis R; Howard B; Boufraqech M; Gara SK; Zhang L; Quezado MM; Nilubol N; Kebebew E Ann Surg Oncol; 2014 Oct; 21(11):3541-7. PubMed ID: 24833102 [TBL] [Abstract][Full Text] [Related]
18. Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers. Kawakami E; Tabata J; Yanaihara N; Ishikawa T; Koseki K; Iida Y; Saito M; Komazaki H; Shapiro JS; Goto C; Akiyama Y; Saito R; Saito M; Takano H; Yamada K; Okamoto A Clin Cancer Res; 2019 May; 25(10):3006-3015. PubMed ID: 30979733 [TBL] [Abstract][Full Text] [Related]
19. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response. Hamed EO; Ahmed H; Sedeek OB; Mohammed AM; Abd-Alla AA; Abdel Ghaffar HM Diagn Pathol; 2013 Jan; 8():11. PubMed ID: 23343214 [TBL] [Abstract][Full Text] [Related]
20. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum]. Wu WJ; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]